Turkcuoglu, PeykanChang, Peter Y.Rentiya, Zubir S.Channa, RoomasaIbrahim, MohamedHatef, ElhamSophie, Raafay2024-08-042024-08-0420110927-3948https://doi.org/10.3109/09273948.2011.580072https://hdl.handle.net/11616/95389Methods: Eight patients who had at least two recurrent episodes of increased activity before MMF and 12 months of documented clinical course before and after MMF were included. The frequencies of attacks before and after MMF were compared. FAF images evaluated. Results: Before MMF, the 8 patients experienced 19 attacks of recurrent disease activity; during MMF therapy, 3 (38%) patients experienced 6 recurrent episodes. The attack frequencies were 1.09 +/-+/- 0.75 before and 0.23 +/-+/- 0.32 during treatment (p == .036). Among the 6 patients who had FAF, surrounding hyperautofluorescent halo was detected in 4 and recurrence occurred in 2 who did not show any changes on the intensity during treatment. Conclusion: In the index study, the employment of MMF has decreased frequency of attacks in recurrent PIC. FAF may be employed to monitor and predict the response to treatment.eninfo:eu-repo/semantics/closedAccessInflammatory Eye DiseaseChoroidal NeovascularizationImmunosuppressive AgentUveitisTherapyResolutionDisordersScleritisArticle1942862922177080910.3109/09273948.2011.5800722-s2.0-79960672974N/AWOS:000292915300014Q3